Q4 2020 Holdings
Filed 2021-02-16 | 13 holdings | $924.0K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-02-24) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Black Diamond Therapeutcs, Inc.(BDTX) | Common | 09203E105 | $1.4M | 43,615 | 59.7% |
| Autolus Therapeutics Limited(AUTL) | Common | 05280R100 | $355.0K | 39,740 | 38.4% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $104.3K | 3,370,982 | 11.3% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $81.9K | 2,388,337 | 8.9% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $79.7K | 2,355,557 | 8.6% |
| Oncorus, Inc. | Common | 68236R103 | $76.8K | 2,377,031 | 8.3% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $64.8K | 3,898,422 | 7.0% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $37.6K | 308,686 | 4.1% |
| MEI Pharma, Inc. | Common | 552798202 | $26.8K | 10,137,859 | 2.9% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $25.6K | 1,423,794 | 2.8% |
| Epizyme, Inc.(EPZMEUR)A | Common | 29428V104 | $25.3K | 2,331,534 | 2.7% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $17.3K | 539,648 | 1.9% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $16.7K | 337,291 | 1.8% |
| Merus N.V. | Common | N5749R100 | $12.3K | 700,879 | 1.3% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $7.0K | 128,162 | 0.3% |
| Avrobio, Inc. | Common | 05455M100 | $5.1K | 364,285 | 0.2% |